España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Lexaria Bioscience
LEXX
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$2.91
0.12
4.30%
At Close: -
$2.82
-0.09
-3.09%
After Hours: 5:58 PM EDT
15 minutes delayed
Get Report
Watch
Q3 2024 Earnings were released on Fri Jul 12th, during market hours
Lexaria Bioscience (LEXX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lexaria Bioscience (NASDAQ:LEXX) Stock
Lexaria Bioscience Stock (NASDAQ: LEXX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 12, 2024
Lexaria Bioscience Q3 EPS $(0.13) Misses $(0....
Benzinga Newsdesk
Wednesday, July 10, 2024
HC Wainwright & Co. Initiates Coverage On Lex...
Benzinga Newsdesk
Monday, July 08, 2024
Lexaria Receives 3 New Patents For Antiviral ...
Benzinga Newsdesk
Tuesday, June 18, 2024
Lexaria Bioscience Hires CRO To Oversee 12-We...
Benzinga Newsdesk
Wednesday, June 05, 2024
Lexaria Bioscience Announces Progress In Huma...
Benzinga Newsdesk
Tuesday, June 04, 2024
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, May 30, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Thursday, May 23, 2024
Lexaria Awards Contract To A CRO To Perform T...
Benzinga Newsdesk
Tuesday, May 21, 2024
Lexaria Granted Patent #21: Compositions and ...
Benzinga Newsdesk
Friday, May 17, 2024
Lexaria Bioscience shares are trading higher ...
Benzinga Newsdesk
Lexaria Bioscience Begins Dosing In GLP-1 Ani...
Benzinga Newsdesk
Monday, May 06, 2024
Lexaria Announces New Research Program To Eva...
Benzinga Newsdesk
Tuesday, April 30, 2024
Lexaria To Receive $4.7M Gross Proceeds In Wa...
Benzinga Newsdesk
Tuesday, April 16, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Lexaria Receives Ethics Review Board Approval...
Benzinga Newsdesk
Thursday, March 14, 2024
Lexaria Appoints Nelson Cabatuan As Chief Fin...
Benzinga Newsdesk
Tuesday, March 12, 2024
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Thursday, March 07, 2024
Lexaria Bioscience Hires Contract Research Or...
Benzinga Newsdesk
Tuesday, March 05, 2024
Maxim Group Maintains Buy on Lexaria Bioscien...
Benzinga Newsdesk
Watching Lexaria Bioscience; Traders Circulat...
Benzinga Newsdesk
Lexaria To Begin Diabetes And Weight Loss Ani...
Benzinga Newsdesk
Friday, March 01, 2024
Lexaria Announces FDA Clearance For Its Plann...
Benzinga Newsdesk
Wednesday, February 28, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, February 27, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Thursday, February 15, 2024
Why Lexaria Bioscience (LEXX) Shares Are Moving
Henry Khederian
Lexaria Bioscience Announces $3.6M Registered...
Benzinga Newsdesk
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, January 30, 2024
Lexaria's Submits Investigational New Drug Ap...
Benzinga Newsdesk
Tuesday, January 16, 2024
Lexaria Bioscience Unveils Planned 2024 GLP-1...
Benzinga Newsdesk
Thursday, January 11, 2024
Lexaria Bioscience Corp. Proprietary Drug-Del...
Benzinga Newsdesk
Tuesday, January 09, 2024
Lexaria Bioscience Corp. Improves Delivery, E...
Benzinga Newsdesk
Thursday, January 04, 2024
Lexaria's Patented Technology Improved The Or...
Benzinga Newsdesk
Thursday, December 07, 2023
Lexaria Bioscience Corp. Announces That The C...
Benzinga Newsdesk
Thursday, November 30, 2023
Lexaria Bioscience Corp Files For Resale Of U...
Benzinga Newsdesk
Tuesday, November 28, 2023
Lexaria Bioscience Announces Additional Inter...
Benzinga Newsdesk
Monday, November 27, 2023
Lexaria Bioscience shares are trading higher ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Tuesday, November 21, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Thursday, November 02, 2023
Lexaria Bioscience Secretary Awarded $18K Worth of Stock Options
Benzinga Insights
Wednesday, November 01, 2023
Lexaria Bioscience Corp. Expands Studies Of P...
Benzinga Newsdesk
Tuesday, October 31, 2023
Chief Executive Officer at Lexaria Bioscience Acquires Company Stock Options Worth 30,000 Shares
Benzinga Insights
President at Lexaria Bioscience Acquires Company Stock Options Worth 30,000 Shares
Benzinga Insights
Lexaria Bioscience Corp. Evaluating Proprieta...
Benzinga Newsdesk
Wednesday, October 18, 2023
On October 17, Lexaria Bioscience Corp Got N...
Benzinga Newsdesk
Friday, October 13, 2023
Lexaria Enters New Global Exclusive Collaboration And License Agreement With SulfoSyn; Global Exclusivity For All Non-Pharmaceutical Applications Of DehydraTECH-Sulforaphane Has Been Awarded
Happy Mohamed
Thursday, October 12, 2023
Lexaria Granted Two New Patents In Canada; Ca...
Benzinga Newsdesk
Friday, September 29, 2023
Lexaria Bioscience Announced A Registered Dir...
Benzinga Newsdesk
Thursday, September 21, 2023
Lexaria To Evaluate Impact Of DehydraTECH On ...
Benzinga Newsdesk
Wednesday, August 30, 2023
Lexaria Provides Update On Investigational New Drug Application Progress With The FDA For Its Planned U.S. Phase 1b Hypertension Clinical Trial Designated As HYPER-H23-1
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch